Veru Announces New England Journal of Medicine Evidence
- Phase 3 Clinical Study Met Primary and Key Secondary Endpoints - - Primary Endpoint: Sabizabulin Treatment Showed Statistically Significant and...
Source: globenewswire.com
Alan Skolnick News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Alan Skolnick. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Alan Skolnick Today - Breaking & Trending Today
Newly published study shows cancer drug cuts risk of death for hospitalized high-risk COVID-19 patients
After the results were first released in April, Veru asked the FDA for emergency use authorization of sabizabulin.
Source: cbsnews.com
Why Veru Stock Soared Today - TechStory
Veru Inc (VERU) stock is up 1.83% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.
Source: techstory.in
Why Veru Stock Soared Today | The Motley Fool
Wall Street is growing more bullish on the biotech's prospects.
Source: fool.com